Enzo Biochem
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Enzo Biochem generated cash of -$26,259,000, which is more than the previous year. Cash used in financing activities reached the amount of -$4,193,000 last year. Net change in cash is therefore -$31,002,000.
Cash Flow
| 2015 | -3.7M | -1.75M | 6.22M |
|---|---|---|---|
| 2016 | 53.12M | -1.51M | -1.93M |
| 2017 | -205K | -1.74M | -1.66M |
| 2018 | -2.73M | -1.94M | 559K |
| 2019 | 4.80M | -8.12M | 4.19M |
| 2020 | -17.17M | -2.17M | 7.00M |
| 2021 | 387K | -34.49M | -242K |
| 2022 | -16.59M | 25.22M | -241K |
| 2023 | -36.97M | 98.98M | -1.12M |
| 2024 | -26.25M | -545K | -4.19M |
ENZ Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 83.37M | 22.60M | 14.27M | 48.61M | 60.89M | 60.04M | 64.16M | 67.77M | 18.10M | 17.45M |
Operating activities | ||||||||||
Net income | -26.07M | 20.28M | -18.26M | 7.87M | -28.52M | 2.48M | -10.32M | -2.50M | 45.28M | -2.28M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.27M | 2.68M | 2.82M | 2.65M | 2.78M | 3.03M | 3.13M | 3.59M | 3.84M | 3.78M |
Stock-based compensation expense | 2.29M | 3.14M | 2.33M | 1.63M | 1.76M | 1.79M | 0 | 1.55M | 1.23M | 1.09M |
| Deferred income tax benefit | 2.29M | 3.14M | 2.33M | 1.63M | 1.76M | 1.79M | 0 | 1.55M | 1.23M | 1.09M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 2.47M | 5.03M | -1.29M | -1.11M | 1.61M | 2.40M | -1.77M | -3.24M | -4.79M | -2.00M |
Inventories | 1.09M | -334K | -2.73M | -4.93M | 85K | -572K | -413K | 92K | 466K | 1.15M |
Accounts payable | -7.73M | 1.15M | 390K | -395K | 1.21M | -2.50M | -887K | 515K | 1.10M | 394K |
Cash generated by operating activities | -26.25M | -36.97M | -16.59M | 387K | -17.17M | 4.80M | -2.73M | -205K | 53.12M | -3.7M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 28.69M | -30.06M | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -545K | -2.76M | -3.47M | -4.43M | -2.17M | -8.12M | -1.88M | -1.75M | -1.53M | -1.78M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -545K | 98.98M | 25.22M | -34.49M | -2.17M | -8.12M | -1.94M | -1.74M | -1.51M | -1.75M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 386K | 0 | 97K | 0 | 167K | 886K | 453K | 90K | 6.68M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -3.71M | -1.13M | -269K | -339K | -411K | 4.09M | -327K | -2.12M | -91.90M | -463K |
Cash used in financing activities | -4.19M | -1.12M | -241K | -242K | 7.00M | 4.19M | 559K | -1.66M | -1.93M | 6.22M |
Net Change In Cash | -31.00M | 60.77M | 8.32M | -34.34M | -12.28M | 855K | -4.12M | -3.61M | 49.66M | 654K |
Cash at end of period | 52.37M | 83.37M | 22.60M | 14.27M | 48.61M | 60.89M | 60.04M | 64.16M | 67.77M | 18.10M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |